Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver

Caroline    S.    Stokes; Frank        Lammert; Marcin        Krawczyk
doi:10.2174/0929867324666170508144409
Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) affects millions of individuals on a global scale and currently no gold standard treatment exists. The risk of developing NAFLD is considerably higher with increasing body mass index. Consequently, weight loss should be recommended to all overweight patients with fatty liver. However, lifestyle interventions, irrespective of weight status, may also influence the condition. The aim herein is to present examples of short-term interventions which assess direct effects of dietary-related components on hepatic steatosis.
Methods: This review includes studies with short-term dietary-related interventions of up to 16 weeks that evaluate their efficacy in reducing intrahepatic lipid contents (hepatic steatosis). This review primarily focuses on the three main macronutrients: dietary carbohydrates, fats and proteins.
Results: High saturated fat intake and high consumption of carbohydrates, particularly from simple sugars such as fructose are reported as risk factors for hepatic steatosis. Overall, shortterm hypocaloric diets have shown beneficial effects in reducing intrahepatic lipid contents. Macronutrient manipulations such as carbohydrate restriction as well as the consumption of unsaturated fatty acids are also reported to have efficacious effects.
Conclusion: This review highlights the different dietary interventions that can influence hepatic steatosis in the short term, illustrating both pro and anti-steatotic effects.
Keywords: Carbohydrate, fructose, hepatic steatosis, hypocaloric, nutrition, protein, vitamin D.
« Previous Next »
[1] 
Ray, K. NAFLD-the next global epidemic. Nat. Rev. Gastroenterol. Hepatol.,  2013, 10(11), 621.
[http://dx.doi.org/10.1038/nrgastro.2013.197] [PMID:  24185985] 
[2] 
European Association for the Study of the Liver (EASL);
European Association for the Study of Diabetes (EASD);
European Association for the Study of Obesity (EASO).
EASL-EASD-EASO Clinical Practice Guidelines for the
management of non-alcoholic fatty liver disease. J. Hepatol.,  2016, 64(6), 1388-1402.
[http://dx.doi.org/10.1016/j.jhep.2015.11.004] [PMID:  27062661] 
[3] 
Krawczyk, M.; Bonfrate, L.; Portincasa, P. Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol.,  2010, 24(5), 695-708.
[http://dx.doi.org/10.1016/j.bpg.2010.08.005] [PMID:  20955971] 
[4] 
Dulai, P.S.; Sirlin, C.B.; Loomba, R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J. Hepatol.,  2016, 65(5), 1006-1016.
[http://dx.doi.org/10.1016/j.jhep.2016.06.005] [PMID:  27312947] 
[5] 
Ferraioli, G.; Tinelli, C.; De Silvestri, A.; Lissandrin, R.; Above, E.; Dellafiore, C.; Poma, G.; Di Gregorio, M.; Maiocchi, L.; Maserati, R.; Filice, C. The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis. Liver Int.,  2016, 36(12), 1860-1866.
[http://dx.doi.org/10.1111/liv.13207] [PMID:  27439331] 
[6] 
Brunt, E.M.; Tiniakos, D.G. Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol.,  2010, 16(42), 5286-5296.
[http://dx.doi.org/10.3748/wjg.v16.i42.5286] [PMID:  21072891] 
[7] 
Chalasani, N.; Younossi, Z.; Lavine, J.E.; Diehl, A.M.; Brunt, E.M.; Cusi, K.; Charlton, M.; Sanyal, A.J. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology,  2012, 55(6), 2005-2023.
[http://dx.doi.org/10.1002/hep.25762] [PMID:  22488764] 
[8] 
Hannah, W.N., Jr; Harrison, S.A. Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease. Dig. Dis. Sci.,  2016, 61(5), 1365-1374.
[http://dx.doi.org/10.1007/s10620-016-4153-y] [PMID:  27052013] 
[9] 
Thoma, C.; Day, C.P.; Trenell, M.I. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol.,  2012, 56(1), 255-266.
[http://dx.doi.org/10.1016/j.jhep.2011.06.010] [PMID:  21723839] 
[10] 
Lin, W.Y.; Wu, C.H.; Chu, N.F.; Chang, C.J. Efficacy and safety of very-low-calorie diet in Taiwanese: a multicenter randomized, controlled trial. Nutrition,  2009, 25(11-12), 1129-1136.
[http://dx.doi.org/10.1016/j.nut.2009.02.008] [PMID:  19592223] 
[11] 
Petersen, K.F.; Dufour, S.; Befroy, D.; Lehrke, M.; Hendler, R.E.; Shulman, G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes,  2005, 54(3), 603-608.
[http://dx.doi.org/10.2337/diabetes.54.3.603] [PMID:  15734833] 
[12] 
Steven, S.; Hollingsworth, K.G.; Al-Mrabeh, A.; Avery, L.; Aribisala, B.; Caslake, M.; Taylor, R. Very-low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiologic changes in responders and nonresponders. Diabetes Care,  2016, 39(5), 808-815.
[http://dx.doi.org/10.2337/dc15-1942] 
[13] 
Lewis, M.C.; Phillips, M.L.; Slavotinek, J.P.; Kow, L.; Thompson, C.H.; Toouli, J. Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes. Surg.,  2006, 16(6), 697-701.
[http://dx.doi.org/10.1381/096089206777346682] [PMID:  16756727] 
[14] 
Viljanen, A.P.; Iozzo, P.; Borra, R.; Kankaanpää, M.; Karmi, A.; Lautamäki, R.; Järvisalo, M.; Parkkola, R.; Rönnemaa, T.; Guiducci, L.; Lehtimäki, T.; Raitakari, O.T.; Mari, A.; Nuutila, P. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J. Clin. Endocrinol. Metab.,  2009, 94(1), 50-55.
[http://dx.doi.org/10.1210/jc.2008-1689] [PMID:  18957499] 
[15] 
Arslanow, A.; Teutsch, M.; Walle, H.; Grünhage, F.; Lammert, F.; Stokes, C.S. Short-term hypocaloric high-hiber and high-protein diet improves hepatic steatosis assessed by Controlled Attenuation Parameter. Clin. Transl. Gastroenterol.,  2016, 7(6)e176
[http://dx.doi.org/10.1038/ctg.2016.28] [PMID:  27311064] 
[16] 
de Lédinghen, V.; Vergniol, J.; Foucher, J.; Merrouche, W.; le Bail, B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int.,  2012, 32(6), 911-918.
[http://dx.doi.org/10.1111/j.1478-3231.2012.02820.x] [PMID:  22672642] 
[17] 
Kirk, E.; Reeds, D.N.; Finck, B.N.; Mayurranjan, S.M.; Patterson, B.W.; Klein, S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology,  2009, 136(5), 1552-1560.
[http://dx.doi.org/10.1053/j.gastro.2009.01.048] [PMID:  19208352] 
[18] 
Bian, H.; Hakkarainen, A.; Lundbom, N.; Yki-Järvinen, H. Effects of dietary interventions on liver volume in humans. Obesity (Silver Spring),  2014, 22(4), 989-995.
[http://dx.doi.org/10.1002/oby.20623] [PMID:  24115747] 
[19] 
Ouyang, X.; Cirillo, P.; Sautin, Y.; McCall, S.; Bruchette, J.L.; Diehl, A.M.; Johnson, R.J.; Abdelmalek, M.F. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol.,  2008, 48(6), 993-999.
[http://dx.doi.org/10.1016/j.jhep.2008.02.011] [PMID:  18395287] 
[20] 
Volynets, V.; Küper, M.A.; Strahl, S.; Maier, I.B.; Spruss, A.; Wagnerberger, S.; Königsrainer, A.; Bischoff, S.C.; Bergheim, I. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig. Dis. Sci.,  2012, 57(7), 1932-1941.
[http://dx.doi.org/10.1007/s10620-012-2112-9] [PMID:  22427130] 
[21] 
Kang, H.; Greenson, J.K.; Omo, J.T.; Chao, C.; Peterman, D.; Anderson, L.; Foess-Wood, L.; Sherbondy, M.A.; Conjeevaram, H.S. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am. J. Gastroenterol.,  2006, 101(10), 2247-2253.
[http://dx.doi.org/10.1111/j.1572-0241.2006.00719.x] [PMID:  17032189] 
[22] 
Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J. Hepatol.,  2007, 47(5), 711-717.
[http://dx.doi.org/10.1016/j.jhep.2007.06.020] [PMID:  17850914] 
[23] 
Parks, E.J.; Krauss, R.M.; Christiansen, M.P.; Neese, R.A.; Hellerstein, M.K. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J. Clin. Invest.,  1999, 104(8), 1087-1096.
[http://dx.doi.org/10.1172/JCI6572] [PMID:  10525047] 
[24] 
Toshimitsu, K.; Matsuura, B.; Ohkubo, I.; Niiya, T.; Furukawa, S.; Hiasa, Y.; Kawamura, M.; Ebihara, K.; Onji, M. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition,  2007, 23(1), 46-52.
[http://dx.doi.org/10.1016/j.nut.2006.09.004] [PMID:  17140767] 
[25] 
Sevastianova, K.; Santos, A.; Kotronen, A.; Hakkarainen, A.; Makkonen, J.; Silander, K.; Peltonen, M.; Romeo, S.; Lundbom, J.; Lundbom, N.; Olkkonen, V.M.; Gylling, H.; Fielding, B.A.; Rissanen, A.; Yki-Järvinen, H. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am. J. Clin. Nutr.,  2012, 96(4), 727-734.
[http://dx.doi.org/10.3945/ajcn.112.038695] [PMID:  22952180] 
[26] 
Johnston, R.D.; Stephenson, M.C.; Crossland, H.; Cordon, S.M.; Palcidi, E.; Cox, E.F.; Taylor, M.A.; Aithal, G.P.; Macdonald, I.A. No difference between high-fructose and
high-glucose diets on liver triacylglycerol or biochemistry
in healthy overweight men. Gastroenterology,,  2013, 145(5), 1016-1025.e1012. 
[http://dx.doi.org/10.1053/j.gastro.2013.07.012] 
[27] 
Ngo Sock, E.T.; Lê, K.A.; Ith, M.; Kreis, R.; Boesch, C.; Tappy, L. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br. J. Nutr.,  2010, 103(7), 939-943.
[http://dx.doi.org/10.1017/S0007114509992819] [PMID:  19930762] 
[28] 
Lecoultre, V.; Egli, L.; Carrel, G.; Theytaz, F.; Kreis, R.; Schneiter, P.; Boss, A.; Zwygart, K.; Lê, K.A.; Bortolotti, M.; Boesch, C.; Tappy, L. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity (Silver Spring),  2013, 21(4), 782-785.
[http://dx.doi.org/10.1002/oby.20377] [PMID:  23512506] 
[29] 
Yki-Järvinen, H. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients,  2015, 7(11), 9127-9138.
[http://dx.doi.org/10.3390/nu7115454] [PMID:  26556368] 
[30] 
Maersk, M.; Belza, A.; Stødkilde-Jørgensen, H.; Ringgaard, S.; Chabanova, E.; Thomsen, H.; Pedersen, S.B.; Astrup, A.; Richelsen, B. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am. J. Clin. Nutr.,  2012, 95(2), 283-289.
[http://dx.doi.org/10.3945/ajcn.111.022533] [PMID:  22205311] 
[31] 
Silbernagel, G.; Machann, J.; Unmuth, S.; Schick, F.; Stefan, N.; Häring, H.U.; Fritsche, A. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br. J. Nutr.,  2011, 106(1), 79-86.
[http://dx.doi.org/10.1017/S000711451000574X] [PMID:  21396140] 
[32] 
Chung, M.; Ma, J.; Patel, K.; Berger, S.; Lau, J.; Lichtenstein, A.H. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am. J. Clin. Nutr.,  2014, 100(3), 833-849.
[http://dx.doi.org/10.3945/ajcn.114.086314] [PMID:  25099546] 
[33] 
Mager, D.R.; Patterson, C.; So, S.; Rogenstein, C.D.; Wykes, L.J.; Roberts, E.A. Dietary and physical activity patterns in children with fatty liver. Eur. J. Clin. Nutr.,  2010, 64(6), 628-635.
[http://dx.doi.org/10.1038/ejcn.2010.35] [PMID:  20216561] 
[34] 
Volynets, V.; Machann, J.; Küper, M.A.; Maier, I.B.; Spruss, A.; Königsrainer, A.; Bischoff, S.C.; Bergheim, I. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur. J. Nutr.,  2013, 52(2), 527-535.
[http://dx.doi.org/10.1007/s00394-012-0355-z] [PMID:  22543623] 
[35] 
Koopman, K.E.; Caan, M.W.; Nederveen, A.J.; Pels, A.; Ackermans, M.T.; Fliers, E.; la Fleur, S.E.; Serlie, M.J. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial. Hepatology,  2014, 60(2), 545-553.
[http://dx.doi.org/10.1002/hep.27149] [PMID:  24668862] 
[36] 
Browning, J.D.; Baker, J.A.; Rogers, T.; Davis, J.; Satapati, S.; Burgess, S.C. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr.,  2011, 93(5), 1048-1052.
[http://dx.doi.org/10.3945/ajcn.110.007674] [PMID:  21367948] 
[37] 
Letexier, D.; Diraison, F.; Beylot, M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr.,  2003, 77(3), 559-564.
[http://dx.doi.org/10.1093/ajcn/77.3.559] [PMID:  12600843] 
[38] 
Buttriss, J.L.; Stokes, C.S. Dietary fibre and health: an overview. Nutr. Bull.,  2008, 33(3), 186-200.
[http://dx.doi.org/10.1111/j.1467-3010.2008.00705.x] 
[39] 
Chang, H.C.; Huang, C.N.; Yeh, D.M.; Wang, S.J.; Peng, C.H.; Wang, C.J. Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. Plant Foods Hum. Nutr.,  2013, 68(1), 18-23.
[http://dx.doi.org/10.1007/s11130-013-0336-2] [PMID:  23371785] 
[40] 
Hudgins, L.C.; Seidman, C.E.; Diakun, J.; Hirsch, J. Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am. J. Clin. Nutr.,  1998, 67(4), 631-639.
[http://dx.doi.org/10.1093/ajcn/67.4.631] [PMID:  9537610] 
[41] 
Bortolotti, M.; Kreis, R.; Debard, C.; Cariou, B.; Faeh, D.; Chetiveaux, M.; Ith, M.; Vermathen, P.; Stefanoni, N.; Lê, K.A.; Schneiter, P.; Krempf, M.; Vidal, H.; Boesch, C.; Tappy, L. High protein intake reduces intrahepatocellular lipid deposition in humans. Am. J. Clin. Nutr.,  2009, 90(4), 1002-1010.
[http://dx.doi.org/10.3945/ajcn.2008.27296] [PMID:  19710199] 
[42] 
van der Meer, R.W.; Hammer, S.; Lamb, H.J.; Frölich, M.; Diamant, M.; Rijzewijk, L.J.; de Roos, A.; Romijn, J.A.; Smit, J.W. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J. Clin. Endocrinol. Metab.,  2008, 93(7), 2702-2708.
[http://dx.doi.org/10.1210/jc.2007-2524] [PMID:  18430773] 
[43] 
van Herpen, N.A.; Schrauwen-Hinderling, V.B.; Schaart, G.; Mensink, R.P.; Schrauwen, P. Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J. Clin. Endocrinol. Metab.,  2011, 96(4), E691-E695.
[http://dx.doi.org/10.1210/jc.2010-2243] [PMID:  21252252] 
[44] 
Utzschneider, K.M.; Bayer-Carter, J.L.; Arbuckle, M.D.; Tidwell, J.M.; Richards, T.L.; Craft, S. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br. J. Nutr.,  2013, 109(6), 1096-1104.
[http://dx.doi.org/10.1017/S0007114512002966] [PMID:  22849970] 
[45] 
Westerbacka, J.; Lammi, K.; Häkkinen, A.M.; Rissanen, A.; Salminen, I.; Aro, A.; Yki-Järvinen, H. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab.,  2005, 90(5), 2804-2809.
[http://dx.doi.org/10.1210/jc.2004-1983] [PMID:  15741262] 
[46] 
Bozzetto, L.; Prinster, A.; Annuzzi, G.; Costagliola, L.; Mangione, A.; Vitelli, A.; Mazzarella, R.; Longobardo, M.; Mancini, M.; Vigorito, C.; Riccardi, G.; Rivellese, A.A. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care,  2012, 35(7), 1429-1435.
[http://dx.doi.org/10.2337/dc12-0033] [PMID:  22723581] 
[47] 
Bjermo, H.; Iggman, D.; Kullberg, J.; Dahlman, I.; Johansson, L.; Persson, L.; Berglund, J.; Pulkki, K.; Basu, S.; Uusitupa, M.; Rudling, M.; Arner, P.; Cederholm, T.; Ahlström, H.; Risérus, U. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr.,  2012, 95(5), 1003-1012.
[http://dx.doi.org/10.3945/ajcn.111.030114] [PMID:  22492369] 
[48] 
Girard, J.; Perdereau, D.; Foufelle, F.; Prip-Buus, C.; Ferré, P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J.,  1994, 8(1), 36-42.
[http://dx.doi.org/10.1096/fasebj.8.1.7905448] [PMID:  7905448] 
[49] 
Clarke, S.D. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol.,  2001, 281(4), G865-G869.
[http://dx.doi.org/10.1152/ajpgi.2001.281.4.G865] [PMID:  11557505] 
[50] 
Chan, D.C.; Watts, G.F.; Gan, S.; Wong, A.T.; Ooi, E.M.; Barrett, P.H. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity. Arterioscler. Thromb. Vasc. Biol.,  2010, 30(5), 1043-1050.
[http://dx.doi.org/10.1161/ATVBAHA.109.202275] [PMID:  20150556] 
[51] 
Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O’Dea, K.; Desmond, P.V.; Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J. Hepatol.,  2013, 59(1), 138-143.
[http://dx.doi.org/10.1016/j.jhep.2013.02.012] [PMID:  23485520] 
[52] 
Keys, A.; Menotti, A.; Karvonen, M.J.; Aravanis, C.; Blackburn, H.; Buzina, R.; Djordjevic, B.S.; Dontas, A.S.; Fidanza, F.; Keys, M.H. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol.,  1986, 124(6), 903-915.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a114480] [PMID:  3776973] 
[53] 
Zhu, F.S.; Liu, S.; Chen, X.M.; Huang, Z.G.; Zhang, D.W. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J. Gastroenterol.,  2008, 14(41), 6395-6400.
[http://dx.doi.org/10.3748/wjg.14.6395] [PMID:  19009658] 
[54] 
Scorletti, E.; Bhatia, L.; McCormick, K.G.; Clough, G.F.; Nash, K.; Hodson, L.; Moyses, H.E.; Calder, P.C.; Byrne, C.D.; Study, W. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology,  2014, 60(4), 1211-1221.
[http://dx.doi.org/10.1002/hep.27289] [PMID:  25043514] 
[55] 
Tanaka, N.; Sano, K.; Horiuchi, A.; Tanaka, E.; Kiyosawa, K.; Aoyama, T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol.,  2008, 42(4), 413-418.
[http://dx.doi.org/10.1097/MCG.0b013e31815591aa] [PMID:  18277895] 
[56] 
Cussons, A.J.; Watts, G.F.; Mori, T.A.; Stuckey, B.G. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J. Clin. Endocrinol. Metab.,  2009, 94(10), 3842-3848.
[http://dx.doi.org/10.1210/jc.2009-0870] [PMID:  19622617] 
[57] 
Gudbrandsen, O.A.; Wergedahl, H.; Liaset, B.; Espe, M.; Mørk, S.; Berge, R.K. Dietary single cell protein reduces fatty liver in obese Zucker rats. Br. J. Nutr.,  2008, 100(4), 776-785.
[http://dx.doi.org/10.1017/S0007114508960906] [PMID:  18346305] 
[58] 
Bortolotti, M.; Maiolo, E.; Corazza, M.; Van Dijke, E.; Schneiter, P.; Boss, A.; Carrel, G.; Giusti, V.; Lê, K.A.; Quo Chong, D.G.; Buehler, T.; Kreis, R.; Boesch, C.; Tappy, L. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin. Nutr.,  2011, 30(4), 494-498.
[http://dx.doi.org/10.1016/j.clnu.2011.01.006] [PMID:  21288612] 
[59] 
Aller, R.; Izaola, O.; Gómez, S.; Tafur, C.; González, G.; Berroa, E.; Mora, N.; González, J.M.; de Luis, D.A. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur. Rev. Med. Pharmacol. Sci.,  2015, 19(16), 3118-3124.
[PMID:  26367736] 
[60] 
Chung, G.E.; Kim, D.; Kwak, M.S.; Yang, J.I.; Yim, J.Y.; Lim, S.H.; Itani, M. The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. Clin. Mol. Hepatol.,  2016, 22(1), 146-151.
[http://dx.doi.org/10.3350/cmh.2016.22.1.146] [PMID:  27044765] 
[61] 
Dasarathy, J.; Periyalwar, P.; Allampati, S.; Bhinder, V.; Hawkins, C.; Brandt, P.; Khiyami, A.; McCullough, A.J.; Dasarathy, S. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int.,  2014, 34(6), e118-e127.
[http://dx.doi.org/10.1111/liv.12312] [PMID:  24118743] 
[62] 
Barchetta, I.; Angelico, F.; Del Ben, M.; Baroni, M.G.; Pozzilli, P.; Morini, S.; Cavallo, M.G. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med.,  2011, 9, 85.
[http://dx.doi.org/10.1186/1741-7015-9-85] [PMID:  21749681] 
[63] 
Bril, F.; Maximos, M.; Portillo-Sanchez, P.; Biernacki, D.; Lomonaco, R.; Subbarayan, S.; Correa, M.; Lo, M.; Suman, A.; Cusi, K. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J. Hepatol.,  2015, 62(2), 405-411.
[http://dx.doi.org/10.1016/j.jhep.2014.08.040] [PMID:  25195551] 
[64] 
Li, L.; Zhang, L.; Pan, S.; Wu, X.; Yin, X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Dig. Dis. Sci.,  2013, 58(8), 2376-2382.
[http://dx.doi.org/10.1007/s10620-013-2658-1] [PMID:  23589141] 
[65] 
Eliades, M.; Spyrou, E.; Agrawal, N.; Lazo, M.; Brancati, F.L.; Potter, J.J.; Koteish, A.A.; Clark, J.M.; Guallar, E.; Hernaez, R. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther.,  2013, 38(3), 246-254.
[http://dx.doi.org/10.1111/apt.12377] [PMID:  23786213] 
[66] 
Wang, D.Q.; Portincasa, P.; Neuschwander-Tetri, B.A. Steatosis in the liver. Compr. Physiol.,  2013, 3(4), 1493-1532.
[http://dx.doi.org/10.1002/cphy.c130001] [PMID:  24265237] 
[67] 
Hyppönen, E.; Boucher, B.J.; Berry, D.J.; Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes,  2008, 57(2), 298-305.
[http://dx.doi.org/10.2337/db07-1122] [PMID:  18003755] 
[68] 
Targher, G.; Bertolini, L.; Scala, L.; Cigolini, M.; Zenari, L.; Falezza, G.; Arcaro, G. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis.,  2007, 17(7), 517-524.
[http://dx.doi.org/10.1016/j.numecd.2006.04.002] [PMID:  16928437] 
[69] 
Sharifi, N.; Amani, R.; Hajiani, E.; Cheraghian, B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine,  2014, 47(1), 70-80.
[http://dx.doi.org/10.1007/s12020-014-0336-5] [PMID:  24968737] 
[70] 
Papapostoli, I.; Lammert, F.; Stokes, C.S. Effect of Short-term vitamin D correction on hepatic steatosis as quantified by Controlled Attenuation Parameter (CAP). J. Gastrointestin. Liver Dis.,  2016, 25(2), 175-181.
[PMID:  27308648] 
[71] 
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol.,  2016, 64(6), 1388-1402.
[http://dx.doi.org/10.1016/j.jhep.2015.11.004] [PMID:  27062661] 
[72] 
Anstee, Q.M.; Seth, D.; Day, C.P. Genetic factors that affect
risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology,  2016, 150(8), 1728-1744.e1727. 
[73] 
Krawczyk, M.; Portincasa, P.; Lammert, F. PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin. Liver Dis.,  2013, 33(4), 369-379.
[http://dx.doi.org/10.1055/s-0033-1358525] [PMID:  24222094] 
[74] 
Krawczyk, M.; Stachowska, E.; Milkiewicz, P.; Lammert, F.; Milkiewicz, M. Reduction of caloric intake might override the prosteatotic effects of the PNPLA3 p.I148M and TM6SF2 p.E167K variants in patients with fatty liver: ultrasound-based prospective study. Digestion,  2016, 93(2), 139-148.
[http://dx.doi.org/10.1159/000441185] [PMID:  26745555] 
[75] 
Marzuillo, P.; Grandone, A.; Perrone, L.; del Giudice, E.M. Weight loss allows the dissection of the interaction between abdominal fat and PNPLA3 (adiponutrin) in the liver damage of obese children. J. Hepatol.,  2013, 59(5), 1143-1144.
[http://dx.doi.org/10.1016/j.jhep.2013.06.027] [PMID:  23845393] 
Rights & Permissions Print Cite
Article Metrics
32
5
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0929867324666170508144409	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X
Current Medicinal Chemistry

Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver

Abstract Play Pause

Related Journals

Related Books

Related Articles

Abstract
